PULSE BIOSCIENCES, INC. — Director's Dealing 2020

May 20, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Pulse Biosciences, Inc. (PLSE)
CIK: 0001625101
Period of Report: 2020-05-18

Reporting Person: Clark Kenneth A (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-05-18	Stock Option (right to buy)	$10.66	A	20000	Acquired	2030-05-18	Common Stock (20000)	Direct
2020-05-18	Stock Option (right to buy)	$10.66	A	14071	Acquired	2030-05-18	Common Stock (14071)	Direct

Footnotes

F1: The shares subject to the option will vest in equal monthly installments over a one year period, subject to the Reporting Person's continued service through each vesting date.

F2: The shares subject to the option will vest in equal quarterly installments over a one year period, subject to the Reporting Person's continued service through each vesting date.